NCT03469310View on ClinicalTrials.gov

Minimizing Narcotic Analgesics After Endocrine Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

March 9, 2018

Primary Completion Date

December 21, 2019

Study Completion Date

October 2, 2020

Conditions
Parathyroid DiseasesParathyroid AdenomaParathyroid HyperplasiaThyroid CancerThyroid NoduleThyroid NeoplasmsThyroid GoitreThyroid Diseases
Interventions
DRUG

Acetaminophen 500Mg Cap

non-narcotic medication first with narcotic as second choice

DRUG

Tylenol #3 Oral Tablet

Narcotic medication first

DRUG

Tramadol

non-narcotic medication first with narcotic as second choice

Trial Locations (1)

78539

GME General Surgery Clinic, Edinburg

All Listed Sponsors
lead

Minerva A Romero Arenas

OTHER

NCT03469310 - Minimizing Narcotic Analgesics After Endocrine Surgery | Biotech Hunter | Biotech Hunter